Lung Fibrosis Interstitial, Post-COVID-19 Syndrome
Conditions
Brief summary
the aim of this study will be to investigate the effect of aerobic exercises vs incentive spirometer device on post-covid patients with residual lung diseases.
Detailed description
To our knowledge, there have been no enough studies that investigated the effect of aerobic exercise and incentive spirometer in pulmonary rehabilitation on post-covid syndrome patients. Therefore, this study may open up ways to other researchers to investigate and build up on this effect if present and address such an important issue. The finding of this proposed work may help patients with post-covid syndrome and complain of lung diseases by addressing their complains of symptoms like chest pain, dyspnea, and cough and provide a possible solution to enhance their quality of life and increase their participation in daily life activities. Patients of post-covid syndrome with residual lung problems will be recruited after approval of ethical committee of the faculty of physical therapy, Cairo university. All participants will sign a written informed consent form. The subjects will be randomly assigned into one of three groups: * Group I (experimental) will receive aerobic exercises program and traditional chest physiotherapy. * Group II (experimental) will receive incentive spirometer device treatment and traditional chest physiotherapy. * Group III (control) will receive traditional chest physiotherapy only. The measures will be taken before and after treatment program.
Interventions
OTHERAerobic Exercises
Aerobic Exercises
DEVICEIncentive Spirometer Device
is a handheld medical device used to help patients improve the functioning of their lungs. By training patients to take slow and deep breaths, this simplified spirometer facilitates lung expansion and strengthening. Patients inhale through a mouthpiece, which causes a piston inside the device to rise. This visual feedback helps them monitor their inspiratory effort. Incentive spirometers are commonly used after surgery or other illnesses to prevent pulmonary complications.
1. Breathing exercise. 2. Postural drainage. 3. Percussion. 4. Coughing. 5. Vibration.
Sponsors
Cairo University
McCarious Nahad Aziz Abdelshaheed Stephens
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
40 Years to 85 Years
Healthy volunteers
No
Inclusion criteria
* Hemodynamic stable (MAP not less than 60mmHg, systolic pressure \>80mmHg and diastolic pressure not \<60mmHg) * Age from 40 to 85 years. * Both sexes. * All patients were positive covid-19 infected patients and passed at least 4 weeks after confirmation. * All patients suffer from respiratory complications. * All patients included are actively breathing. * All patients included are fully aware and conscious.
Exclusion criteria
* Hemodynamic Instability. * Severe Head Injury. * Increased intracranial pressure. * Anemic Hb\<8. * Active Smoking. * Severe Bronchospasm. * Low BP (systole \<80, diastole \<60). * Subcutaneous Emphysema. * Rip Fractures. * Untreated Pneumothorax.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Pulmonary function tests (PFTs). | Before and After the treatment program. 8 weeks | to measure the lungs' capacities and volumes like: FVC, FEV1, and PEF. |
| Peripheral oxygen saturation level (SpO2). | Before and After the treatment program. 8 weeks | measures the amount of oxygen carried in the blood stream in peripheral limbs. |
| Six minutes' walk distance test (6MWD). | Before and After the treatment program. 8 weeks | measures the aerobic capacity of the lungs by testing the maximum distance the subject can walk in a 6 minutes time. |
| Heart rate measurements. (HR). | through all the treatment procedures. 8 weeks | it measures the number of heart bumps in a minute in order to deliver blood to all of the body during Rest and Activity. |
Countries
Egypt
Outcome results
None listed